Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8318945
Metalloprotein inhibitors
granted patentUS 8318939
Kinase inhibitors
granted patentUS 8318467
Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes
granted patentUS 8314141
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
granted patentUS 8309566
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted patentUS 8309543
Compositions useful as inhibitors of voltage-gated sodium channels
granted patentUS 8304385
Macrocyclic tetrazolyl hepatitis C serine protease inhibitors
granted patentUS 8304414
Pyrazole compounds useful as protein kinase inhibitors
granted patentUS 8304408
Wnt signaling inhibitors, and methods for making and using them
granted patentUS 8299100
Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane perm
granted patentUS 8299261
1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivative
granted patentUS 8293901
MAPK/ERK kinase inhibitors
granted patentUS 8293724
Therapeutic applications of fatty acid amide hydrolase inhibitors
granted patentUS 8293878
Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibi
granted patentUS 8288400
Compositions useful as inhibitors of protein kinases
granted patentUS 8288382
Diaminothiazoles useful as Axl inhibitors
granted patentUS 8288539
Dipeptidyl peptidase inhibitors
granted patentUS 8288537
Caspase inhibitors and uses thereof
granted patentUS 8288536
Kinase inhibitors
granted patentUS 8283309
Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors
granted patentUS 8278297
Protein kinase inhibitors
granted patentUS 8278306
C-met protein kinase inhibitors
granted patentUS 8278299
Pyrimidinediamine kinase inhibitors
granted patentUS 8278450
Kinase inhibitors
granted